271 results on '"Dickson, Dennis"'
Search Results
2. Correction: Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
3. MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy
4. Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
5. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis
6. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors
7. HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases
8. Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease
9. Letter to the editor on: Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions by Park et al. (2022)
10. TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
11. Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
12. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
13. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
14. Hippocampal mitophagy alterations in MAPT-associated frontotemporal dementia with parkinsonism.
15. Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures
16. Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
17. Neuroimmune proteins can differentiate between tauopathies
18. Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation
19. Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
20. Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels
21. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy
22. Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease
23. Neuropathology and molecular diagnosis of Synucleinopathies
24. Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy
25. Cellular and pathological heterogeneity of primary tauopathies
26. Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease
27. TDP-43 Pathology in Alzheimer’s Disease
28. Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study
29. Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
30. MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features
31. Astrocyte-derived clusterin suppresses amyloid formation in vivo
32. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
33. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations
34. Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
35. Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
36. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
37. Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
38. Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40
39. Correction to: Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy
40. Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy
41. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers
42. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
43. Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant
44. Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers
45. The neuropathological diagnosis of Alzheimer’s disease
46. C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
47. Tau exhibits unique seeding properties in globular glial tauopathy
48. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
49. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
50. Long-read sequencing across the C9orf72 ‘GGGGCC’ repeat expansion: implications for clinical use and genetic discovery efforts in human disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.